Group 1 - The company Infit (300582.SZ) announced that its wholly-owned subsidiary, Hangzhou Infit Equity Investment Co., Ltd., will invest in Qinghai Spring Warm Flower Biotechnology Co., Ltd. and its existing shareholders through a capital increase and share transfer agreement [1] - The investment includes a cash contribution of 13.44 million yuan to increase the registered capital of Spring Warm Flower by 1.344 million yuan, with the remaining amount recorded as capital surplus [1] - After the transaction, the company will directly hold 2.62% of the equity in the target company and indirectly hold 3.04% through Blincao Biotechnology [1] Group 2 - This transaction allows the company to deepen its application scenarios in plant/biological lighting, accurately understand customer needs, and iteratively improve LED driver power supplies, sensors, and control systems [2] - The strategic shift from a "single hardware supplier" to a "system solution provider" will enhance customer loyalty and technical barriers, maintaining the company's competitive advantage in the plant (biological) lighting segment [2]

Group 1 - The company announced that its wholly-owned subsidiary, Hangzhou Infit Investment Co., Ltd., will invest 13.44 million yuan in Qinghai Spring Warm Flower Biotechnology Co., Ltd. and acquire shares from existing shareholders [1] - After the transaction, the company will directly hold 2.62% of the target company's equity and indirectly hold 3.04% through Blincao Biotechnology [2] - This transaction aims to enhance the application scenarios of plant/biological lighting, allowing the company to better understand customer needs and transition from a "single hardware supplier" to a "system solution provider" [2]